Cytokine-induced apoptosis of beta-thalassemia/hemoglobin e erythroid progenitor cells via nitric oxide-mediated process in vitro

Acta Haematologica

Volumn 126, Issue 4, 2011, Pages 224-230

  Kheansaard, Wasinee ^a   Panichob, Prapaporn ^a   Fucharoen, Suthat ^b   Tanyong, Dalina I ^a,b  

^a Faculty of Medical Technology   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Thalassemia hemoglobin E; Apoptosis; Cytokines; Nitric oxide

Indexed keywords

GAMMA INTERFERON; HEMOGLOBIN E; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; APOPTOSIS; BETA-THALASSEMIA; CELLS, CULTURED; CYTOKINES; ENZYME INHIBITORS; ERYTHROID PRECURSOR CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMOGLOBIN E; HETEROZYGOTE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RECOMBINANT PROTEINS; RNA, MESSENGER; THAILAND; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 81255141168     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000329903     Document Type: Article

References (25)

1. Alan R, Galanello CR, Pennell DJ, Cunning MJ, Vichinsky E: Thalassemia. Hematology (Am Soc Hematol Educ Program) 2004: 14-34.
2. Rund D, Rachmilewitz E: Beta-thalassemia. N Eng J Med 2005; 353: 1135-1146.
3. Chekir A, Laradi S, Ferchichi S, Khelil A, Feki M, Amri F, Selmi H, Bejaoui M, Miled A: Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 2003; 338: 79-86. (Pubitemid 37456693)
4. Winichagoon P, Svasti S, Munkongdee T, Chaiya W, Boonmongkol P, Chantrakul N, Fuchareon S: Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system. Transl Res 2008; 152: 178-184.
5. Morabito N, Russo GT, Gaudio A, Lasco A, Catalano A, Morini E, Franchina F, Maisano D, La Rosa M, Plota M, Crifò A, Meo A, Frisina N: The 'lively' cytokines network in beta-thalassemia major-related osteoporosis. Bone 2007; 40: 1588-1594. (Pubitemid 46766649)
6. Carlo D, Anna C, Johanna S, Riccardo H, Vincenzo P, Albert N, Rosanna S, Angela P, Vito P: TNF-αand IFN-γare overexpressed in the bone marrow of Fanconi anemia patients and TNF-αsuppresses erythropoiesis in vitro. Blood 2003; 102: 2053-2059.
7. Bertero M, Caligaris C: Anemia of chronic disorders in systemic autoimmune diseases. Haematologica 1997; 82: 375-381. (Pubitemid 28023326)
8. Chung IJ, Lee JJ, Nam CE, Kim HN, Kim YK, Park MR, Cho SH, Kim HJ: Increased inducible nitric oxide synthase expression and nitric oxide concentration in patients with aplastic anemia. Ann Hematol 2003; 82: 104-108. (Pubitemid 36700984)
9. Dumazet H, Matsuda M, Dupouy M, Belloc F, Thiolat D, Marit G, Arock M, Reiffers J, Mossalayi M: Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron. Leukemia 2002; 16: 708-715. (Pubitemid 34449754)
10. Aktan F: iNOS-mediated nitric oxide production and its regulation. Life Sci 2004; 75: 639-653. (Pubitemid 38686696)
11. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthase: structure, function and inhibition. Biochem J 2001; 357: 593-615. (Pubitemid 32735142)
12. Mayer B, Hemmers B: Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 1997; 22: 477-481. (Pubitemid 27515914)
13. Kroncke KD, Fehsel K, Kolb BV: Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998; 113: 147-156. (Pubitemid 28352831)
14. Beck KF, Eberhardt W, Frank S, Huwiler A, Messmer UK, Muhl H: Inducible nitric oxide synthase: role in cellular signaling. J Exp Biol 1999; 202: 654-663.
15. Sun J, Zhang S, Broderick M, Fein H: Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 2003; 3: 276-284. (Pubitemid 40643539)
16. Lithanatudom P, Leecharoenkiat A, Wannatung T, Svasti S, Fucharoen S, Duncan R: A mechanism of ineffective erythropoiesis inβ-thalassemia/HbE disease. Haematologica 2010; 95: 716-723.
17. Donald M: Hematopoietic cytokines. Blood 2008; 111: 485-491.
18. Morceau F, Dicato M, Diederich M: Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediators Inflamm 2009; 2009: 405016.
19. Wanachiwanawin W, Wiener E, Siripanyaphinyo U, Chinprasertsuk S, Mawas F, Fucharoen S, Wickramasinghe S, Pootrakul P, Visudhiphan S: Serum levels of tumor necrosis factor-α, interleukin-1, and interferon-γinβ- thalassemia/HbE and their clinical significance. J Interferon Cytokine Res 1999; 19: 105-111. (Pubitemid 29109626)
20. Garcia MM, Beckman BS: Signal transduction in erythropoiesis. FASEB J 1991; 5: 2958-2964. (Pubitemid 21905837)
21. Unger EF, Thompsom AM, Blank MJ, Temple R: Erythropoiesis-stimulating agents-time for a reevaluation. N Engl J Med 2010; 362: 189-192.
22. Afanas I: Interplay between superoxide and nitric oxide in thalassemia and Fanconi's anemia. Hemoglobin 2006; 30: 113-118.
23. Bernhard B, Andreas K, Katrin S: Nitric oxide (NO): an effector of apoptosis. Cell Death Diff 1999; 6: 969-975.
24. Barthlen C, Klemens S, Rogenhofer J, Stadler N, Unbehaun B: Critical role of nitric oxide for proliferation and apoptosis of bone-marrow cells under septic conditions. Ann Hematol 2000; 79: 249-254.
25. Pawel M, Hanna C, Ewa S, Wlodzimierz M, Marzena O: Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity. Rheumatol Int DOI: 10.1007/s00296-010-1692-y.